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The etiologic factors in the development of autoimmune thyroid diseases (AITDs) are not fully understood.
We investigated the role of skewed X-chromosome inactivation (XCI) mosaicism in female predisposition
to AITDs. One hundred and ten female AITDs patients (81 Hashimoto’s thyroiditis (HT), 29 Graves’ disease
(GD)), and 160 female controls were analyzed for the androgen receptor locus by the HpaII/polymerase
chain reaction assay to assess XCI patterns in DNA extracted from peripheral blood cells. In addition,
thyroid biopsy, buccal mucosa, and hair follicle specimens were obtained from five patients whose blood
revealed an extremely skewed pattern of XCI, and the analysis was repeated. Skewed XCI was observed in
DNA from peripheral blood cells in 28 of 83 informative patients (34%) as compared with 10 of 124
informative controls (8%, Po0.0001). Extreme skewing was present in 16 patients (19%), but only in three
controls (2.4%, Po0.0001). The buccal mucosa, and although less marked, the thyroid specimens also
showed skewing. Analysis of two familial cases showed that only the affected individuals demonstrate
skewed XCI patterns. Based on these results, skewed XCI mosaicism may play a significant role in the
pathogenesis of AITDs.
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Introduction
Hashimoto’s thyroiditis (HD) and Graves’ disease (GD)
are autoimmune thyroid diseases associated with multiple
genetic factors. Although the pathogenesis is poorly
understood, a widely accepted model suggests an inherited
background, which predisposes the subjects to autoimmu-
nity. Additional intrinsic and extrinsic factors such as
hormones and the environment may ultimately trigger or
contribute to the development of the disease phenotype.1
Extensive linkage genome screens during the past decade
have resulted in the identification of several thyroid-
specific susceptibility genes and/or loci, but confirmation
through multiple population studies is still awaited for
the majority of these loci.1,2 A common feature of auto-
immune diseases, including autoimmune thyroid diseases
(AITDs), is an increased prevalence in women when
compared with men. The most striking sex differences are
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observed in AITDs, scleroderma, Sjo¨gren’s syndrome, and
systemic lupus erythematosus, which are diseases where
over 80% of the patients are females.3
It has been demonstrated that risk of autoimmunity
could be increased by a lack of exposure to self-antigens in
the thymus and the presence of autoreactive T cells.4 – 6
Disturbances in the X-chromosome inactivation (XCI)
process provide a potential mechanism whereby the lack
of exposure to self-antigens could occur,7,8 including
AITDs.9,10 X-chromosome inactivation is a physiologic
process that takes place in early female development and
results in the transcriptional silencing of one of the pair of
X chromosomes.11 As a result of this epigenetic regulation,
a random inactivation of the X chromosome inherited
from either parent occurs and normal female subjects
are thus a mosaic of two cell populations. It is therefore
an attractive hypothesis that skewed XCI could lead to
the escape of X-linked self-antigens from presentation in
the thymus or in other peripheral sites that are involved
in tolerance induction, inadequate thymic deletion, and
finally loss of T-cell tolerance. Indeed, we recently
observed skewed XCI in blood cells of women with
scleroderma.12
Based on our observation that an association exists
between skewed XCI and female predisposition to auto-
immunity, we hypothesized that skewed XCI may be
involved in the pathogenesis of AITDs, particularly in the
hematopoietic compartment. We observed extremely
skewed XCI in the blood samples of a significant propor-
tion of female patients with AITDs.
Methods
Patients and pedigree analysis
Caucasian women diagnosed with AITDs (n¼110), and
healthy female controls with no history of autoimmune
disease and cancer (n¼160) were included in the study.
Among the patients, 81 were diagnosed with HT and 29
with GD. The mean ages were 44.8714.1 (mean7SD) years
for AITDs (46714.2 years in the Hashimoto patients, and
40.6713.2 years in the Graves’ patients), and 46710 for
controls. The duration of the symptoms was 5.777.4 years
among the AITDs patients (5.777 years in the Hashimoto
patients and 678.5 years in the Graves’ patients). The
mean age of diagnosis was 39712 years. All of the patients
had attended the outpatient clinics of the Endocrinology
and Metabolic Diseases Department of Ankara University
School of Medicine for at least 1 year since the onset of
disease. Patients were randomly chosen for the study.
All clinical investigations described in this manuscript
were conducted in accordance with the guidelines in the
Declaration of Helsinki (http://www.wma.net). The ethics
review board of the participating institutions approved the
study protocol. Informed consent was obtained from all
subjects.
The diagnosis of HD was made by the existence of a firm
goitre in combination with elevated thyroid auto-anti-
bodies (thyroglobulin and/or thyroid peroxidase), a low
ultrasonographic echogenity of the gland, and demonstra-
tion of lymphocytic infiltration by fine-needle aspiration
biopsy and/or biochemical hypothyroidism. The diagnosis
of GD was based on biochemical hyperthyroidism, and a
diffuse symmetrical goitre in combination with positive
thyroid antibodies (thyroglobulin, thyroid peroxidase or
TSH receptor). In addition, thyroid ophthalmopathy and/
or diffuse hyperplasia on an isotope scan or ultrasonogra-
phy demonstrating homogenous echo texture may accom-
pany the clinical picture.
Following the XCI studies, a complete pedigree analysis
was carried out for 64 individuals informative for the AR
polymorphism with medical follow-up of reported AITDs
among family members when possible. Owing to emigra-
tion or unwillingness to contribute family information,
data could not be obtained from the remaining 19
participants. Family history of AITDs was determined by
reviewing the probands’ pedigree to determine the number
of relatives affected by these autoimmune diseases. Only
first- and second-degree relatives were counted. A positive
family history was noted if one additional AITD was
documented by medical review.
X-chromosome inactivation analysis
Genotyping of a highly polymorphic CAG repeat in the
androgen-receptor (AR) gene was performed to assess the
XCI patterns as described elsewhere.12,13 Densitometric
analysis of the alleles was performed at least twice for
each sample using the MultiAnalyst version 1.1 software. A
corrected ratio (CrR) was calculated by dividing the ratio of
the predigested sample (upper/lower allele) by the ratio of
the nonpredigested sample for normalization of the ratios
that were obtained from the densitometric analyses. The
use of CrR compensates for preferential amplification
of the shorter allele when the number of PCR cycles
increases.14 A skewed population is defined as a cell
population with greater than 80% expression of one of
the AR alleles. This corresponds to CrR values ofo0.33 or43.
Haplotype analysis
Human MapPairs Version 10 purchased from Research
Genetics (currently available by Invitrogen, CA, USA) was
used to screen the X chromosome. Site-specific PCR, 6%
polyacrylamide gel electrophoresis, and silver staining
techniques were used for genotyping the individuals. Gels
were manually pictured and genotyped. Cyrillic program
(version 2) was used to generate the haplotypes. A total of
27 X-chromosome-specific DNA markers from the Map-
Pairs Panel were genotyped. Map order and physical
positions (Mb) of the additional polymorphic DNA markers
were obtained from USCS genome browser (The University
of California Santa Cruz, CA, USA http://genome.ucsc.edu/).
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Statistical methods
The results from control and test groups in XCI studies
were compared by w2 test with Yate’s correction.
Results
PCR-based X-inactivation study of peripheral blood
XCI status was informative in 83 of the 110 AITDs patients
and in 124 of the 160 controls. Some heterozygous
individuals were considered uninformative since only
those whose alleles resolve adequately for densitometric
analyses were included in the study. Skewed XCI (480%
skewing) was observed in 28 of the 83 patients (34%), and
10 of the 124 controls (8%) (Po0.0001). When the data for
the two groups of AITDs patients was analyzed indepen-
dently, 23/67 (34.33%, Po0.0001) of the Hashimoto’s
patients and 5/16 (31.25%, P¼0.0167) of the Graves’
patients were found to display the skewed XCI in blood.
More importantly, extremely skewed XCI, defined as
490% inactivation of one allele, was present in 16 patients
(19%), and in only three controls (2.4%, Po0.0001) (see
Table 1). Extremely skewed XCI is a rare event in the
general population. It has been reported in only 1–2% of
women aged 20–40 years, and in 2–4% of women aged
55–72 years.15,16 The distribution of XCI skewing in the
general population is thought to be mainly due to chance
deviations from 50:50 as a result of the limited number of
embryonic cells present (4–20) at the time of XCI.17 Age
alone is unlikely to influence the strikingly bimodal data in
our AITDs patients (Figure 1). We did not observe a shift
towards the skewed range in older patients and controls.
PCR-based X-inactivation study of thyroid biopsy,
buccal mucosa, and hair follicle specimens
Thyroid biopsy, buccal mucosa, and hair follicle specimens
were obtained from five patients (04-121, 04-198, 04-214,
04-221, and 04-225). Their blood XCI profile displayed
almost exclusive representation of only one allele of the AR
polymorphism in their methylation-sensitive PCR assay,
which indicates extremely skewed XCI. Five randomly
selected patients showed skewing in the same direction for
all tissues, except hair follicle, that in the thyroid being less
marked than blood and buccal cells (Figure 2). Hair follicle
specimens had a random XCI pattern. The allele ratios are
given in Table 2.
Pregnancy history and pedigree analysis
Characteristics of the AITDs patients with skewed and
random XCI are shown in Table 3. Only those patients with
a complete pregnancy and family history are included in
this table. The pedigrees of many AITDs probands with
skewed XCI versus those with random XCI were interesting
in two aspects. First, recurrent spontaneous abortions
(defined as three or more pregnancy losses), which have
been shown to be associated with skewed XCI,16,18 occurred
in four of 25 (16%) of our AITDs probands with skewed
XCI. Conversely, a history of recurrent spontaneous abor-
tions was negative both in the patients with random XCI
and in the control group subjects (Po0.0199). Although the
etiology of recurrent abortions in thyroid autoimmunity
remains unknown, women who present with thyroid
antibodies in the first trimester of pregnancy have a two-
to four-fold increase in their miscarriage rates.19
Second, a positive family history, particularly in the
skewed group, was apparent (12/25, 48% in the skewed;
and 10/39, 25.6% in the random groups). We therefore
contacted all of the 12 probands in an attempt to extend
the X-chromosome inactivation studies to other family
members. Initially, a positive response was received from
three families, but blood samples could be obtained from
Table 1 Proportion of patients and controls with skewed
X-chromosome inactivation
Degree of
skewing (%) No. (%) observed with skewing
Autoimmune thyroiditis
(n¼83)
Control females
(n¼ 124)
90+ 16 (19.27) 3 (2.41)
80–89 12 (14.45) 7 (5.64)
70–79 6 (7.22) 22 (17.74)
60–69 16 (19.27) 29 (23.38)
50–59 33 (39.75) 63 (50.80)
For comparison by w2, Po0.0001 (480% skewing); Po0.0001 (90+%
skewing).
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Figure 1 Distribution of X-inactivation patterns according to age in
AITDs patients and control subjects.
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the family members of only two probands (04-445, Family
1; and 04-298, Family 2). An important observation
emerges from a study of these families: only the affected
individuals demonstrate skewed XCI patterns. For example,
XCI is extremely skewed in the affected sister and mother of
04-445 (Family 1), but random in the two unaffected sisters.
The inactive X chromosome here is of maternal origin. In
patient 04-298 (Family 2), skewing in the 80–89% range is
noted for her affected sister, but unfortunately her mother
was not informative for the AR polymorphism. Interest-
ingly, the inactive X chromosome appears to be of paternal
origin in Family 2 (Supplementary Figures 1 and 2).
Haplotype analysis
Because XCI segregates as a heritable trait associated with
the disease in two generations of Family 1, we performed
haplotype analysis by using polymorphic X-chromosomal
markers to determine possible segregation between the
Table 2 X-chromosome inactivation patterns in blood,
thyroid, buccal mucosa, and hair follicle specimens
Sample 04-121 04-198 04-214 04-221 04-225
Blood 94:6 91:9 84:16 92:8 91:9
Thyroid 72:28 79:21 76:24 74:26 64:36
Buccal 86:14 97:3 87:13 89:11 82:18
Hair 60:40 50:50 () 59:41 52:48
04-225
04-121
04-198
+- +- +-+
M Thy. biopsy Buccal Hair
04-214
04-221
Blood
-Hpa ll
Figure 2 X-inactivation analysis of androgen receptor locus. PCR
products of undigested () and HpaII-digested (þ ) DNA from
peripheral blood, thyroid biopsy, buccal, and hair follicle samples of
AITDs patients 04-121, 04-198, 04-214, 04-221, and 04-225 are
shown. Two alleles are seen in undigested samples, whereas a single
allele resulting from extremely skewed XCI is clearly visible in all
peripheral blood samples. Allele ratios are given in the text and in
Table 2. M: marker (pUC mix 8), 331 and 242 bp fragments are visible.
Table 3 Characteristics of the patients who are informative for X-chromosome inactivation status
Patient Birth date Disease onset Pregnancy history Sex and birth date of children Family history of first-degree relatives
90+% skewing
1 04-136a 1975 2004 G0,P0,A0 () ()
2 04-127b 1975 2003 G0,P0,A0 () ()
3 04-138b 1962 1980 G7,P0,A7 () Two sisters
4 04-298b 1979 2003 G1,P1,A0 F03 Mother, one sister
5 04-445b 1961 2000 G1,P1,A0 F88 Mother, one sister
6 04-198b,c 1935 2004 G2,P2,A0 M68,M72 ()
7 04-221b,c 1958 2000 G4,P2,A2 M91,F94 Two sisters
8 04-250b 1967 1996 G7,P2,A5 M89,M93 One son
9 04-226b,c 1963 2004 G3,P3,A0 M83,F88,M98 One sister
10 04-233a 1967 1990 G4,P3,A1 M88,F94,M01 ()
11 04-121b,c 1957 1988 G7,P4,A3 F78,M83,F91,F94 ()
12 04-205b 1927 2003 G6,P5,A1 M47,M50,F52,F53,M55 ()
13 04-225b,c 1936 1975 G6,P6,A0 F56,F58,F60,F62,M64,M66 One daughter
80–89% skewing
14 04-132b 1960 2002 G0,P0,A0 () Mother, one sister
15 04-223b 1956 1988 G0,P0,A0 () Mother, one sister
16 04-105a 1978 1999 G5,P1,A4 M98 ()
17 04-131b 1944 2002 G3,P2,A0 M69,M71 ()
18 04-120b 1956 1994 G3,P3,A0 F75,M77,F78 ()
19 04-107b 1948 1998 G4,P3,A1 F70,F72,F76 ()
20 04-98b 1956 2000 G8,P3,A1 F79,F81,F87 Two daughters
21 04-218b 1941 1991 G4,P3,A1 M61,F63,F67 ()
22 04-108b 1952 1999 G5,P3,A2 F77,F78,M83 ()
23 04-208b 1960 1999 G5,P3,A0 F83,F85,M88 Mother
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disease and marker alleles. Although the size of this family
is not large enough to prove linkage, it still provides
valuable information about the exclusion area on the X
chromosome. This helps to define a minimal critical region
on the X chromosome, which might be associated with
AITDs. Xp11-q13 (GATA144DO4, DXS7132, and AR) and
Xp22 DNA markers (DXS8022, DXS987, and DX9902)
showed concordance among the affected individuals
indicating positive segregation between the disease and
marker alleles. The haplotype structure is shown in
Figure 3. However, lod score20 analysis did not allow
formal acceptance of linkage to any loci mainly due to the
small size of the family.
Discussion
The autoimmune diseases include more than 70 chronic
disorders that affect approximately 5% of the population. A
reduction in sex ratio (male:female) is characteristic of
most such diseases, including AITDs.3 Even though the
Table 3 (Continued)
Patient Birth date Disease onset Pregnancy history Sex and birth date of children Family history of first-degree relatives
24 04-110a 1960 1998 G4,P4,A0 M80,M83,M85,F96 ()
25 04-214b,c 1921 1999 G9,P8,A1 F44,M45,F47,F48,M54,F56,F58,M60 One daughter
70–79% skewing
26 04-203b 1961 2004 G3,P1,A0 M82 ()
27 04-230b 1951 1999 G2,P2,A0 M77,M86 One son
28 04-213b 1947 1998 G7,P3,A0 F67,M68,M71 ()
29 04-228b 1953 2001 G3,P3,A0 M71,M73,M82 ()
30 04-137b 1932 1981 G5,P4,A0 F50,F53,M55,F59 ()
60–69% skewing
31 04-206a 1946 1964 G1,P0,A1 () ()
32 04-92b 1971 1998 G3,P1,A0 F96 Mother
33 04-240b 1975 2003 G2,P1,A0 M00 ()
34 04-139b 1959 2002 G1,P1,A0 M97 ()
35 04-257b 1973 2004 G3,P2,A1 M95,M01 ()
36 04-112b 1952 1999 G2,P2,A0 F72,F77 Mother
37 04-220a 1955 1998 G3,P2,A0 M74,M78 ()
38 04-103b 1962 1986 G6,P2,A1 F82,M92 ()
39 04-251b 1941 1984 G5,P3,A1 M60,M63,M65 Two sisters
40 04-99b 1961 1997 G6,P3,A2 F81,F85,F87 Mother, one sister
41 04-224a 1950 2001 G6,P5,A1 M69,M72,F73,M75,F78 ()
50–59% skewing
42 04-96b 1939 1996 G0,P0,A0 () ()
43 04-242b 1960 1999 G0,P0,A0 () ()
44 04-129b 1982 1998 G0,P0,A0 () Mother
45 04-196b 1956 1999 G6,P1,A0 F93 ()
46 04-231b 1964 2003 G1,P1,A0 M93 ()
47 04-201a 1971 2001 G2,P1,A1 F93 Mother
48 04-95b 1975 2004 G3,P2,A0 F98,M00 ()
49 04-239b 1951 2003 G3,P2,A0 M68,M75 ()
50 04-246b 1961 1996 G2,P2,A0 M78,F81 ()
51 04-200b 1954 1992 G5,P2,A0 M73,M75 Three sisters
52 04-237b 1970 2004 G2,P2,A0 M93,F97 ()
53 04-102b 1964 2003 G3,P2,A1 F95,F87 ()
54 04-204b 1949 2002 G4,P2,A0 F71,M73 ()
55 04-93a 1960 2003 G2,P2,A0 M91,F94 ()
56 04-116a 1960 2003 G4,P2,A0 F86,M89 One brother
57 04-197b 1961 1976 G6,P3,A2 M82,M84,M98 ()
58 04-229b 1938 1980 G3,P3,A0 M61,M63,F65 One sister
59 04-255b 1974 1993 G3,P3,A0 F92,M96,F01 ()
60 04-212a 1958 2002 G4,P3,A0 M76,F80,M84 ()
61 04-238b 1939 2002 G6,P4,A0 M61,M65,F67,M72 ()
62 04-117b 1944 2004 G6,P4,A0 M60,M64,F66,F67 ()
63 04-211a 1950 2002 G6,P6,A0 F66,F67,F72,M84,M85,M86 ()
64 04-243a 1937 1994 G12,P7,A1 M57,M59,F60,F62,M65,M67,F68 ()
G, number of pregnancies; P, para (pregnancies carried to term and delivered); A, spontaneous abortions.
aGraves’ disease.
bHashimoto’s thyroiditis.
cPatients from whom thyroid biopsy samples were obtained.
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female prevalence of autoimmune diseases has been
recognized for over a hundred years, candidate mecha-
nisms that could be important in pathogenesis have been
uncovered only during the past two decades. These include
genetic traits associated with autoimmunity,21 pregnancy-
related microchimerism,22 and disturbances in XCI mosai-
cism in female subjects.12 In this study, we demonstrate
skewed XCI patterns in peripheral blood mononuclear cells
of a significant proportion (34%) of female subjects with
AITDs. Approximately 8% of female control subjects
demonstrate skewed X-inactivation patternsX80:20, which
is consistent with previous estimates.16,18,23 The effect is
more pronounced at patterns of X-inactivation X90:10;
nearly 20% of AITDs patients show such skewing (Supple-
mentary Figure 3), compared with only a few percent of
female control subjects. Our results show that factors
associated with extremely skewed XCI could account for a
significant proportion of female patients with AITDs.
Skewed XCI is a result of primary or secondary causes.
The former is bias in the initial choice of which X
chromosome is inactivated due to germline XIST (X-
inactive-specific transcript) mutations.24 The secondary
causes are deleterious X-linked mutations, X chromosome
rearrangements, aging, twinning, or monoclonal expan-
sion of cells (for a review, see Brown25). We believe that
deleterious X-linked mutations or X chromosome rearran-
gements and their differential expression patterns could
provide a disadvantage to blood and buccal cells, and
possibly to thyroid cells in AITDs patients, and lead to
skewed XCI. This has been supported by our observation
that maternally inherited skewed XCI profile accompanies
the disease phenotype for our AITDs Family 1. We observed
segregation between the disease and marker alleles with
the DNA markers residing on the distal short arm and
pericentromeric regions of the X chromosome in this
family. Although examples of skewed X-inactivation
segregating with a trait have been reported previously,18,26
this is the first example in AITDs to the best of our
knowledge. In a recently published study on a three-
generation kindred, extreme skewing of X inactivation was
documented in three female subjects who have hemophilia
A.26 Since the inactive X was always of paternal origin
in affected female subjects, the authors concluded that
skewing in the family resulted from an abnormality in the
initial choice process. This prevented the X chromosome,
which carried the mutant FVIII allele, from being an
inactive X. In our Family 2 with two affected sisters, the
inactive X chromosome was of paternal origin like the
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Figure 3 Haplotype structure of Family 1. Patient 04-445 was
arbitrarily selected to construct the haplotype. Maternally inherited
haplotype was highlighted with solid black bar. Haplotypes of the
remaining sibs were compared with the reference individual (04-445),
and shared portions were also marked with solid bars. Noninforma-
tiveness in the crossover regions were demonstrated with thin bars.
The regions between the DNA markers DXS8051 and DXS8036 as well
as DXS8014 and AR regions on Xp22 and Xp11-q13 regions,
respectively, were not excluded since positive segregation between
the disease and marker alleles was observed.
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hemophilia A family. Extension of both the XCI and
linkage studies to large cohorts with familial AITDs cases
could prove to be very rewarding in understanding the
relation between skewed XCI and autoimmune thyroidites.
Studies that aim to delineate the medical consequences
of skewed X-inactivation have shown that clinical mani-
festation of X-linked disorders in female subjects could be
influenced by disturbances in the XCI process.27 In
addition, it has been hypothesized that skewed XCI could
be a factor that influences female predisposition to
autoimmunity.7,8 Now that we have demonstrated skewed
patterns of XCI in a significant proportion of female AITD
patients, deviation from the physiological range of XCI
mosaicism could be considered as a potential mechanism
contributing to disease pathogenesis. This is further
supported by the recently reported observation that female
twins with AITDs have a high frequency of skewed XCI.28
Although extremely skewed XCI is rare, it does not
always lead to the development of AITDs. A subsequent
event, such as environmental exposure to viral, chemical,
or other agents may trigger a cascade that results in AITDs.
In addition, the co-inheritance of genetic susceptibility
factors, such as functional variants in vital negative
regulatory molecules of the immune system,29,30 may
exacerbate the effects of skewed XCI and contribute to
the development of autoimmune diseases including AITDs.
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